Royalty Pharma Plc (RPRX)
58.31
-0.74
(-1.25%)
USD |
NASDAQ |
Sep 15, 15:21
Royalty Pharma Price to Book Value : 3.804 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 3.852 |
| September 11, 2026 | 3.824 |
| September 10, 2026 | 3.833 |
| September 09, 2026 | 3.953 |
| September 08, 2026 | 3.953 |
| September 04, 2026 | 4.172 |
| September 03, 2026 | 4.167 |
| September 02, 2026 | 4.117 |
| September 01, 2026 | 4.066 |
| August 31, 2026 | 4.006 |
| August 28, 2026 | 3.970 |
| August 27, 2026 | 4.040 |
| August 26, 2026 | 4.032 |
| August 25, 2026 | 4.049 |
| August 24, 2026 | 4.001 |
| August 21, 2026 | 4.000 |
| August 20, 2026 | 3.952 |
| August 19, 2026 | 4.027 |
| August 18, 2026 | 3.894 |
| August 17, 2026 | 3.878 |
| August 14, 2026 | 3.823 |
| August 13, 2026 | 3.820 |
| August 12, 2026 | 3.863 |
| August 11, 2026 | 3.77 |
| August 10, 2026 | 3.782 |
| Date | Value |
|---|---|
| August 07, 2026 | 3.704 |
| August 06, 2026 | 3.735 |
| August 05, 2026 | 3.767 |
| August 04, 2026 | 3.750 |
| August 03, 2026 | 3.730 |
| July 31, 2026 | 3.812 |
| July 30, 2026 | 3.850 |
| July 29, 2026 | 3.861 |
| July 28, 2026 | 3.912 |
| July 27, 2026 | 3.831 |
| July 24, 2026 | 3.838 |
| July 23, 2026 | 3.850 |
| July 22, 2026 | 3.831 |
| July 21, 2026 | 3.811 |
| July 20, 2026 | 3.738 |
| July 17, 2026 | 3.796 |
| July 16, 2026 | 3.818 |
| July 15, 2026 | 3.674 |
| July 14, 2026 | 3.632 |
| July 13, 2026 | 3.683 |
| July 10, 2026 | 3.681 |
| July 09, 2026 | 3.781 |
| July 08, 2026 | 3.808 |
| July 07, 2026 | 3.771 |
| July 06, 2026 | 3.713 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.67 |
| Johnson & Johnson | 7.536 |
| Merck & Co., Inc. | 8.466 |
| Viatris, Inc. | 1.346 |
| ANI Pharmaceuticals, Inc. | 2.744 |
Price to Book Value Related Metrics
| PE Ratio | 31.04 |
| PS Ratio | 12.08 |
| Price to Free Cash Flow | 50.03 |
| Price | 58.31 |
| Earnings Yield | 3.22% |
| Market Cap | 25.99B |
| Operating PE Ratio | 19.38 |
| Normalized PE Ratio | 33.01 |